Unique ID issued by UMIN | UMIN000042839 |
---|---|
Receipt number | R000048871 |
Scientific Title | Combined Treatment with Hyperbaric Oxygen Therapy and Endovascular therapy FOr Patients with ChrOnic Limb-Threatening Ischemia -Multicenter Randomized Controlled Trial- |
Date of disclosure of the study information | 2021/01/01 |
Last modified on | 2022/09/14 22:32:37 |
Combined Treatment with Hyperbaric Oxygen Therapy and Endovascular therapy FOr Patients with ChrOnic Limb-Threatening Ischemia
HOTFOOT
Combined Treatment with Hyperbaric Oxygen Therapy and Endovascular therapy FOr Patients with ChrOnic Limb-Threatening Ischemia
-Multicenter Randomized Controlled Trial-
HOTFOOT
Japan |
Chronic limb-threatening ischemia
Arteriosclerosis obliterans
Cardiology | Vascular surgery | Radiology |
Cardiovascular surgery | Plastic surgery |
Others
NO
The aim of the present study is to evaluate the effect of combined treatment with hyperbaric oxygen therapy and endovascular therapy on limb outcomes in patients with chronic limb-threatening ischemia.
Safety,Efficacy
Confirmatory
Not applicable
Time to wound healing in 6 months
1.Wound healing rate at 6 months
2.Major lower limb amputation rate at 6 months
3.Amputation free survival at 6 months
4.The rate of re-intervention at 6 months
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
YES
2
Treatment
Device,equipment |
Patients received combined treatment with hyperbaric oxygen therapy(HBOT) and endovascular treatment (Combined treatment group)
A session of HBOT was performed with a chamber pressurized at 2.0 to 2.5 atmospheres absolute and 100% oxygen had been breathed for 90 min. HBOT is scheduled until wound healing has been achieved or until a maximum of 30 sessions has been reached.
Patients received endovascular treatment (Endovascular treatment group)
20 | years-old | <= |
Not applicable |
Male and Female
Patients with chronic limb-threatening ischemia having
1. toe pressure <30 mm Hg, or
SPP <30 mm Hg or TcPO2 <30 mm Hg
2. ischemic ulcer or gangrene, namely Fontaine stage IV, Rutherford classification 5 or 6
3. primary success in endovascular treatment.
1. Patients during pregnancy or breastfeeding
2. Contraindicated patients with hyperbaric oxygen therapy
3. Patients scheduled to undergo LDL apheresis
4. Patients with severe infection (namely, foot infection grade 3 in the Wound, Ischemia, and foot Infection [WIfI] classification)
140
1st name | Kazushi |
Middle name | |
Last name | Urasawa |
Tokeidai memorial hospital
Cardiovascular center
060-0031
2-3 North-1, East 1, Chuo-Ku Sapporo, Hokkaido 060-0031, Japan
0112511221
k-urasawa@tokeidaihosp.or.jp
1st name | Yusuke |
Middle name | |
Last name | Sato |
Tokeidai memorial hospital
Cardiovascular center
0600031
2-3 North-1, East 1, Chuo-Ku Sapporo, Hokkaido 060-0031, Japan
0112511221
toppy1363@gmail.com
Tokeidai memorial hospital, Cardiovascular center
Self-funding
Self funding
Tokeida Memorial Hosptal Clinical Research Ethics Committee
2-3 North-1, East 1, Chuo-Ku Sapporo, Hokkaido 060-0031, Japan
011-251-1221
kojima-pt@tokeidaihosp.or.jp
NO
国保旭中央病院(千葉)、王子総合病院(北海道)、彦根市立病院(滋賀)、恵み野病院(北海道)、名古屋ハートセンター(愛知)、坂総合病院(宮城)、市立札幌病院(北海道)、福井大学病院(福井)、杉田玄白記念公立小浜病院(福井)、天陽会中央病院(鹿児島)
2021 | Year | 01 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2020 | Year | 11 | Month | 01 | Day |
2020 | Year | 11 | Month | 19 | Day |
2021 | Year | 02 | Month | 01 | Day |
2027 | Year | 07 | Month | 31 | Day |
2020 | Year | 12 | Month | 24 | Day |
2022 | Year | 09 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048871